0
Détail de l'auteur
Auteur Saul Shiffman |
Documents disponibles écrits par cet auteur (8)
Ajouter le résultat dans votre panier Affiner la rechercheComparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving / Saul Shiffman (2000)
Titre : Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving Type de document : document électronique Auteurs : Saul Shiffman, Auteur ; C.A. Elash, Auteur ; Stephanie M. Paton, Auteur ; Chad J. Gwaltney, Auteur ; Jean A. Paty, Auteur ; D.B. Clarke, Auteur ; K.S. Liu, Auteur ; Michael E. Di Marino, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2000 Collection : Addiction num. 95(8) Importance : p.1185-1195 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:efficacité du sevrage
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotineIndex. décimale : TA 6.2.3.1.2 Transcutané Résumé : Aims: To compare a transdermal nicotine patch designed for 24-hour wear with one designed for 16-hour wear for relief of craving and withdrawal, particularly in the morning hours.
Design: Smokers were randomly assigned to use one of two common patch regimens: NicoDerm/NiQuitin (24-hour wear, 21 mg nicotine) or Nicotrol/Nicorette (16-hour wear, 15 mg). In a double-dummy design, participants wore two patches during the day, one active, one placebo and one patch while sleeping.
Setting: A smoking cessation research clinic.
Participants: Two hundred and forty-four smokers who suffered morning cravings.
Intervention: Two patch formulations approved and marketed for over-the-counter use in the US--NicoDerm CQ (labeled as 21 mg over 24 hours) and Nicotrol (labeled as 15 mg over 16 hours)--were each used according to its instructions. Smokers also received behavioral counseling.
Measurements: For a week of baseline and 2 weeks after quitting, smokers used palm-top computers to assess craving and withdrawal symptoms several times each day.
Findings: The 21 mg/24-hour patch yielded consistently better control of craving, not only during the morning hours, but throughout the day, and over the 2-week period of abstinence. Additionally, the 21 mg/24-hour patch yielded greater reductions in anxiety, irritability and restlessness. Smokers using the 21 mg/24-hour dosing regimen also experienced longer abstinence than those using the 15 mg/16-hour patch.
Conclusions: These findings demonstrate that 24-hour dosing with a 21 mg patch affords superior relief of craving and withdrawal during the first 2 weeks of abstinence, when symptoms are at their peak, and when relapse is most likely. They confirm the importance of dosing parameters in nicotine replacement products.En ligne : https://doi.org/10.1046/j.1360-0443.2000.95811855.x Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10343 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Comparative risk perceptions of switching to JUUL vs. continued smoking and subsequent switching away from cigarettes : a longitudinal observational study Type de document : document électronique Auteurs : Arielle Seyla, Auteur ; Saul Shiffman, Auteur Editeur : BioMed Central Année de publication : 2023 Collection : BMC Psychology Importance : 14 p. Présentation : tab., graph Langues : Anglais (eng) Catégories : [TABAC] CANDIDATS:e-cigarette
[TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] étude
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique
[TABAC] tabagisme:risqueMots-clés : juul Index. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Background
Evidence indicates that electronic nicotine delivery systems (ENDS) pose lower risk than cigarettes; however, many smokers harbor misperceptions that ENDS are equally or more harmful, possibly deterring them from switching. This study examines whether comparative risk perceptions of JUUL vs. smoking are associated with subsequent switching, among smokers who recently purchased JUUL.
Methods
N = 16,996 current established smokers who recently purchased a JUUL Starter Kit were followed 6 times over 12 months. Comparative risk perceptions were assessed using both direct and indirect measures (i.e., contrasting JUUL and smoking directly in questions, and deriving from separate absolute scales). Repeated-measures logistic regression examined switching across follow-up (no smoking in past 30 days) as a function of baseline risk perceptions, adjusting for demographics and baseline smoking behavior.
Results
Perceiving JUUL as less harmful than smoking was associated with higher switching rates, using both direct (e.g., adjusted odds ratio [AOR] = 1.48 for “JUUL much less” vs. “more/much more harmful”) and indirect (AOR = 1.07, for each 10-unit increase in fraction; AOR = 1.51 for highest (6-100) vs. lowest (0 to < 1) fraction categories) comparative risk measures (all p < 0.0001). Among the subset smoking 10 + cigarettes per day, associations between risk perceptions and switching were more pronounced (AOR = 2.51 for “JUUL much less” vs. “more/much more harmful”;
AOR = 1.81 for 6-100 vs. 0 to < 1 fraction, both p < 0.0001).
Conclusions
Smokers who perceive JUUL as less harmful than cigarettes have higher odds of switching. Future research should examine whether messaging which aligns comparative risk perceptions with current evidence can facilitate switching, especially among heavier smokers.En ligne : https://doi.org/10.1186/s40359-023-01351-8 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10261 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Efficacy of a Nicotine Lozenge for Smoking Cessation Type de document : texte imprimé Auteurs : Saul Shiffman, Auteur ; Carolyn M. Dresler, Auteur ; Peter Hajek, Auteur Editeur : American Medical Association (AMA) Année de publication : 10/06/2002 Collection : JAMA Internal Medicine num. 162 Importance : p.1267-1276 Note générale : reprint Catégories : [TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:compriméIndex. décimale : TA 6.2.3.1.4 Autres substituts nicotiniques Résumé : Efficacité des pastilles à la nicotine dans le sevrage tabagique En ligne : https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/211489 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=1460 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Efficacy of over-the-counter nicotine patch Type de document : texte imprimé Auteurs : Saul Shiffman, Auteur ; Jane Gorsline, Auteur ; W. Gorodetzky, Auteur Editeur : Oxford University Press Année de publication : 2002 Collection : Nicotine and Tobacco Research num. 4 Importance : p.477-483 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:efficacité du sevrage
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotineIndex. décimale : TA 6.2.3.1.2 Transcutané Résumé : Efficacité du patch à la nicotine en délivrance libre Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2864 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 001579 TA 6.2.3.1.2 SHI E Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Journal of substance abuse treatment : the effectiveness of nicotine patch and nicotine lozenge in very heavy smokers Type de document : texte imprimé Auteurs : Saul Shiffman, Auteur ; Michael Eriksen, Auteur Editeur : Paris [France] : Elsevier Année de publication : 2005 Collection : Journal of Substance Abuse Treatment Importance : p. 50-55 Présentation : tab. Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:constituant:alcaloïde:nicotine
[TABAC] sevrage tabagique:efficacité du sevrage
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotiniqueIndex. décimale : TA 2.4.3.1 Professionnels de la santé Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=3203 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005123 TA 2.4.3.1 SHI E Article/Périodique Bibliothèque FARES Tabac Disponible Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment / Saul Shiffman (21/05/2007)
Titre : Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment Type de document : texte imprimé Auteurs : Saul Shiffman, Auteur ; Mark H. Balabanis, Auteur ; Chad J. Gwaltney, Auteur ; Jean A. Paty, Auteur ; Maryann Gnys, Auteur ; Jon D. Kassel, Auteur ; Mary Hickcox, Auteur ; Stephanie M. Paton, Auteur Editeur : Paris [France] : Elsevier Année de publication : 21/05/2007 Collection : Drug and Alcohol Dependence Note générale : Dans la bibliothèque virtuelle (articles scientifiques) Langues : Anglais (eng) Catégories : [TABAC] étude:enquête:questionnaire
[TABAC] étude:statistique
[TABAC] sevrage tabagique
[TABAC] sevrage tabagique:efficacité du sevrage:rechute
[TABAC] tabagismeIndex. décimale : TA 3.2.2.9 Autres effets (accidents, incendies, cendriers, environnement…) Résumé : Smoking is associated with particular moods and activities, but it is not known whether there are individual differences in these associations and whether these differences are associated with success in smoking cessation.We assessed such associations using ecological momentary assessment: real-world, real-time data, collected by palm-top computer. Two hundred and fourteen smokers participating in a smoking cessation study provided data during ad lib smoking at baseline. Participants recorded moods and activities each time they smoked and, for comparison, at randomly selected non-smoking occasions. Situational associations with smoking were captured by examining the associations between smoking and antecedents considered relevant to lapse risk: negative affect (NA), arousal, socializing with others, the presence of others smoking, and consumption of coffee and alcohol. The associations varied across participants, confirming individual differences in situational smoking associations. Survival analyses revealed that only the NA pattern predicted first lapse. The effect was only seen in EMA assessments of NA smoking, and was not captured by questionnaire measures of negative affect smoking, which did not predict lapse risk. Moreover, the effect was not mediated by nicotine dependence. En ligne : https://doi.org/10.1016%2Fj.drugalcdep.2007.05.017 Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2693 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002088 TA 3.2.2.9 SHI P Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Real-world efficacy of prescription and over-the-counter nicotine replacement therapy Type de document : document électronique Auteurs : Saul Shiffman, Auteur ; Clyde N. Rolf, Auteur ; Stephen J. Hellebusch, Auteur ; Jane Gorsline, Auteur ; W. Gorodetzky, Auteur ; Yu-Kun Chiang, Auteur ; Debra S. Schleusener, Auteur ; Michael E. Di Marino, Auteur Editeur : Society for the study of addiction to alcohol and other drugs Année de publication : 2001 Collection : Addiction num. 97 Importance : p.505-516 Langues : Anglais (eng) Catégories : [TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:chewing-gum
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:patch à la nicotine
[TABAC] sevrage tabagique:méthode de sevrage:méthode individuelle:approche pharmacologique:substitution nicotiniqueIndex. décimale : TA 6.2.3.1 Substitution nicotinique Résumé : Aims To assess smoking cessation rates achieved with nicotine gum and patch in simulated over-the-counter (OTC) and actual prescription (Rx) settings.
Design Separate open-label studies with gum and patch in OTC and Rx settings.
Participants There were multiple samples: OTC gum: 2981 smokers; OTC patch: 2367; Rx gum: 324; Rx patch: 669.
Interventions All smokers received active nicotine replacement. In the OTC setting, smokers self-selected doses of nicotine gum (2 or 4mg Nicorette®) or patch (21, 14 or 7mg NicoDerm® CQ). No intervention was provided. In the Rx setting, smokers were prescribed gum or patch by their physician.
Measurements Biochemically verified continuous smoking abstinence was assessed at 6 weeks (28-day abstinence) and 6 months.
Findings OTC success rates were consistently higher than Rx rates: differences were significant at 6 weeks for both patch [OR = 1.45 (1.05–1.98)] and gum [OR = 2.92 (1.58–5.40)], and remained significant at 6 months for patch [OR = 3.63; (1.74–7.61)] but not gum [OR = 1.37; (0.73–2.58)]. Among OTC gum users, 16.1% were abstinent at 6 weeks and 8.4% at 6 months. For Rx gum users, abstinence rates were 7.7% at 6 weeks and 7.7% at 6 months. With OTC patch, 19.0% were abstinent at 6 weeks and 9.2% at 6 months. With Rx patch, abstinence rates were 16.0% at 6 weeks and 3.0% at 6 months.
Conclusions Smoking cessation rates achieved with nicotine gum and patch under OTC conditions were as good as those under real-world prescribing conditions.
En ligne : https://doi.org/10.1046/j.1360-0443.2002.00141.x Format de la ressource électronique : Article en ligne Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=10342 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Titre : Recent advances in the pharmacotherapy of smoking Type de document : texte imprimé Auteurs : John R. Hughes, Auteur ; Michael G. Goldstein, Auteur ; Richard D. Hurt, Auteur ; Saul Shiffman, Auteur Editeur : American Medical Association (AMA) Année de publication : 1999 Collection : JAMA : Journal of the American Medical Association num. 281 (1) Importance : p.72-76 Langues : Anglais (eng) Catégories : [DIVERS] discipline médicale, paramédicale et scientifique:pharmacologie
[TABAC] sevrage tabagique
[TABAC] tabagismeIndex. décimale : TA 6.2.3 Approche pharmacologique Résumé : Since the 1996 publication of guidelines on smoking cessation from the Agency for Health Care Policy and Research and the American Psychiatric Association, several new treatments have become available, including nicotine nasal spray, nicotine inhaler, and bupropion hydrochloride. In addition, nicotine gum and patch have become available over-the-counter. This article reviews the published literature and US Food and Drug Administration and pharmaceutical company reports on these therapies. Based on this review, clinical logic, and experience, we conclude that pharmacotherapy should be made available to all smokers. All currently available therapies appear to be equally efficacious, approximately doubling the quit rate compared with placebo. Concomitant behavioral or supportive therapy increases quit rates and should be encouraged but not required. Combining patch with gum or patch with bupropion may increase the quit rate compared with any single treatment. Because patient characteristics predictive of success with a particular therapy are not yet known, the best treatment choice for an individual patient should be guided by the patient's past experience and preference and the product's adverse effect profile. Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=2588 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 002334 TA 6.2.3. HUH R Article/Périodique Bibliothèque FARES Tabac Consultation sur place
Exclu du prêtAucun avis, veuillez vous identifier pour ajouter le vôtre !
